These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 9276860)
1. Antiarrhythmic agents: current status and perspectives. Mátyus P; Varró A; Papp JG; Wamhoff H; Varga I; Virág L Med Res Rev; 1997 Sep; 17(5):427-51. PubMed ID: 9276860 [No Abstract] [Full Text] [Related]
2. Antiarrhythmic drugs and ion channels: have we made the connection? Carmeliet E J Cardiovasc Electrophysiol; 1999 May; 10(5):755-9. PubMed ID: 10355931 [No Abstract] [Full Text] [Related]
3. [Clinical significance of the use-dependent sodium channel block and reverse use-dependent potassium channel block of class I and class III antiarrhythmic agents and their values to predict drug efficacy]. Sadanaga T; Ogawa S; Okada Y; Handa S Jpn Circ J; 1992; 56 Suppl 5():1474-6. PubMed ID: 1337923 [No Abstract] [Full Text] [Related]
4. Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis. Chay TR J Electrocardiol; 1995; 28 Suppl():191-7. PubMed ID: 8656110 [TBL] [Abstract][Full Text] [Related]
5. The cardiac ion channels: relevance to management of arrhythmias. Roden DM; George AL Annu Rev Med; 1996; 47():135-48. PubMed ID: 8712768 [TBL] [Abstract][Full Text] [Related]
7. Selectivity and toxicity of antiarrhythmic drugs: molecular interactions with ion channels. Katz AM Am J Med; 1998 Feb; 104(2):179-95. PubMed ID: 9528738 [No Abstract] [Full Text] [Related]
8. [New aspects of the molecular effect of anti-arrhythmia agents]. Honerjäger P Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907 [TBL] [Abstract][Full Text] [Related]
9. Putting the Sicilian Gambit to the test. Janse MJ Eur Heart J; 1992 Nov; 13 Suppl F():30-7. PubMed ID: 1335870 [No Abstract] [Full Text] [Related]
10. [The working classification of antiarrhythmic drugs based on the pathogenetic approach to treatment of cardiac arrhythmias]. Lipnitskiĭ TN; Kozlovskiĭ VA Lik Sprava; 2002; (8):26-30. PubMed ID: 12669534 [TBL] [Abstract][Full Text] [Related]
11. [Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects]. Motté G Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():7-16. PubMed ID: 6280631 [No Abstract] [Full Text] [Related]
14. Ranolazine in Cardiac Arrhythmia. Saad M; Mahmoud A; Elgendy IY; Richard Conti C Clin Cardiol; 2016 Mar; 39(3):170-8. PubMed ID: 26459200 [TBL] [Abstract][Full Text] [Related]
15. On the mechanism of action of antiarrhythmic agents. Grant AO Am Heart J; 1992 Apr; 123(4 Pt 2):1130-6. PubMed ID: 1313200 [TBL] [Abstract][Full Text] [Related]
16. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]]. Sulimov VA Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042 [No Abstract] [Full Text] [Related]
18. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Hondeghem LM; Snyders DJ Circulation; 1990 Feb; 81(2):686-90. PubMed ID: 2153477 [TBL] [Abstract][Full Text] [Related]
19. Modulation of spiral wave reentry by K(+) channel blockade. Honjo H; Yamazaki M; Kamiya K; Kodama I Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736 [TBL] [Abstract][Full Text] [Related]
20. Arrhythmias and antiarrhythmic drugs. Urthaler F Ala J Med Sci; 1984 Jul; 21(3):275-83. PubMed ID: 6476289 [No Abstract] [Full Text] [Related] [Next] [New Search]